Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016920791> ?p ?o ?g. }
- W3016920791 abstract "Abstract Background Fragile X syndrome (FXS) is the most frequent cause of inherited intellectual disability and the most commonly identified monogenic cause of autism. Recent studies have shown that long-term pathological consequences of FXS are not solely confined to the central nervous system (CNS) but rather extend to other physiological dysfunctions in peripheral organs. To gain insights into possible immune dysfunctions in FXS, we profiled a large panel of immune-related biomarkers in the serum of FXS patients and healthy controls. Methods We have used a sensitive and robust Electro Chemi Luminescence (ECL)-based immunoassay to measure the levels of 52 cytokines in the serum of n = 25 FXS patients and n = 29 healthy controls. We then used univariate statistics and multivariate analysis, as well as an advanced unsupervised clustering method, to identify combinations of immune-related biomarkers that could discriminate FXS patients from healthy individuals. Results While the majority of the tested cytokines were present at similar levels in FXS patients and healthy individuals, nine chemokines, CCL2, CCL3, CCL4, CCL11, CCL13, CCL17, CCL22, CCL26 and CXCL10, were present at much lower levels in FXS patients. Using robust regression, we show that six of these biomarkers (CCL2, CCL3, CCL11, CCL22, CCL26 and CXCL10) were negatively associated with FXS diagnosis. Finally, applying the K-sparse unsupervised clustering method to the biomarker dataset allowed for the identification of two subsets of individuals, which essentially matched the FXS and healthy control categories. Conclusions Our data show that FXS patients exhibit reduced serum levels of several chemokines and may therefore exhibit impaired immune responses. The present study also highlights the power of unsupervised clustering methods to identify combinations of biomarkers for diagnosis and prognosis in medicine." @default.
- W3016920791 created "2020-04-24" @default.
- W3016920791 creator A5005494726 @default.
- W3016920791 creator A5006759989 @default.
- W3016920791 creator A5009694565 @default.
- W3016920791 creator A5012587745 @default.
- W3016920791 creator A5029165329 @default.
- W3016920791 creator A5045729648 @default.
- W3016920791 creator A5059192489 @default.
- W3016920791 creator A5073485583 @default.
- W3016920791 creator A5084808085 @default.
- W3016920791 creator A5089874264 @default.
- W3016920791 date "2020-04-15" @default.
- W3016920791 modified "2023-10-11" @default.
- W3016920791 title "Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome" @default.
- W3016920791 cites W1552117335 @default.
- W3016920791 cites W169181863 @default.
- W3016920791 cites W1905242322 @default.
- W3016920791 cites W1981395373 @default.
- W3016920791 cites W1985966348 @default.
- W3016920791 cites W1990327166 @default.
- W3016920791 cites W1994817684 @default.
- W3016920791 cites W1998855617 @default.
- W3016920791 cites W1998974902 @default.
- W3016920791 cites W2002353472 @default.
- W3016920791 cites W2018013642 @default.
- W3016920791 cites W2026874107 @default.
- W3016920791 cites W2041513855 @default.
- W3016920791 cites W2052685738 @default.
- W3016920791 cites W2059443686 @default.
- W3016920791 cites W2081596482 @default.
- W3016920791 cites W2143313161 @default.
- W3016920791 cites W2146795905 @default.
- W3016920791 cites W2149919973 @default.
- W3016920791 cites W2161322144 @default.
- W3016920791 cites W2165648215 @default.
- W3016920791 cites W2168353812 @default.
- W3016920791 cites W2284446072 @default.
- W3016920791 cites W2515862236 @default.
- W3016920791 cites W2558965398 @default.
- W3016920791 cites W2590281767 @default.
- W3016920791 cites W2599157542 @default.
- W3016920791 cites W2602934021 @default.
- W3016920791 cites W2620588197 @default.
- W3016920791 cites W2759433538 @default.
- W3016920791 cites W2777753808 @default.
- W3016920791 cites W2797069917 @default.
- W3016920791 cites W2797244528 @default.
- W3016920791 cites W2797458325 @default.
- W3016920791 cites W2886733693 @default.
- W3016920791 cites W2910933666 @default.
- W3016920791 cites W4247183936 @default.
- W3016920791 doi "https://doi.org/10.1186/s12883-020-01715-2" @default.
- W3016920791 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7161166" @default.
- W3016920791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32295518" @default.
- W3016920791 hasPublicationYear "2020" @default.
- W3016920791 type Work @default.
- W3016920791 sameAs 3016920791 @default.
- W3016920791 citedByCount "7" @default.
- W3016920791 countsByYear W30169207912020 @default.
- W3016920791 countsByYear W30169207912021 @default.
- W3016920791 countsByYear W30169207912022 @default.
- W3016920791 countsByYear W30169207912023 @default.
- W3016920791 crossrefType "journal-article" @default.
- W3016920791 hasAuthorship W3016920791A5005494726 @default.
- W3016920791 hasAuthorship W3016920791A5006759989 @default.
- W3016920791 hasAuthorship W3016920791A5009694565 @default.
- W3016920791 hasAuthorship W3016920791A5012587745 @default.
- W3016920791 hasAuthorship W3016920791A5029165329 @default.
- W3016920791 hasAuthorship W3016920791A5045729648 @default.
- W3016920791 hasAuthorship W3016920791A5059192489 @default.
- W3016920791 hasAuthorship W3016920791A5073485583 @default.
- W3016920791 hasAuthorship W3016920791A5084808085 @default.
- W3016920791 hasAuthorship W3016920791A5089874264 @default.
- W3016920791 hasBestOaLocation W30169207911 @default.
- W3016920791 hasConcept C118552586 @default.
- W3016920791 hasConcept C13373296 @default.
- W3016920791 hasConcept C203014093 @default.
- W3016920791 hasConcept C205778803 @default.
- W3016920791 hasConcept C2777630245 @default.
- W3016920791 hasConcept C2780194698 @default.
- W3016920791 hasConcept C2781197716 @default.
- W3016920791 hasConcept C54355233 @default.
- W3016920791 hasConcept C5858377 @default.
- W3016920791 hasConcept C60644358 @default.
- W3016920791 hasConcept C71924100 @default.
- W3016920791 hasConcept C86803240 @default.
- W3016920791 hasConcept C8891405 @default.
- W3016920791 hasConceptScore W3016920791C118552586 @default.
- W3016920791 hasConceptScore W3016920791C13373296 @default.
- W3016920791 hasConceptScore W3016920791C203014093 @default.
- W3016920791 hasConceptScore W3016920791C205778803 @default.
- W3016920791 hasConceptScore W3016920791C2777630245 @default.
- W3016920791 hasConceptScore W3016920791C2780194698 @default.
- W3016920791 hasConceptScore W3016920791C2781197716 @default.
- W3016920791 hasConceptScore W3016920791C54355233 @default.
- W3016920791 hasConceptScore W3016920791C5858377 @default.
- W3016920791 hasConceptScore W3016920791C60644358 @default.
- W3016920791 hasConceptScore W3016920791C71924100 @default.
- W3016920791 hasConceptScore W3016920791C86803240 @default.